Translocation and dissemination of botulinum neurotoxin from the intestinal tract

Toxicon

Volumn 147, Issue , 2018, Pages 13-18

  Fujinaga, Yukako ^a   Popoff, Michel R ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b INSTITUT PASTEUR   (France)

Author keywords

Acetylcholine; Botulinum neurotoxin; Cdc42; E cadherin; Intestinal barrier; M cell; Transcytosis

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN; HEMAGGLUTININ; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEINASE; UVOMORULIN;

ACETYLCHOLINE RELEASE; ARTICLE; CELL JUNCTION; CHOLINERGIC NERVE CELL; DIGESTIVE SYSTEM; ENZYME DEGRADATION; FLACCID PARALYSIS; HUMAN; INTESTINE; INTESTINE CELL; INTESTINE EPITHELIUM CELL; INTESTINE FLUID; INTESTINE MUCOSA; NERVE CELL; NEUROMUSCULAR JUNCTION; PH; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SUBMUCOSA; TRANSCYTOSIS; ANIMAL; DRUG EFFECT; INTESTINE ABSORPTION; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN TRANSPORT; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BOTULINUM TOXINS; HEMAGGLUTININS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MICE; NEURONS; PROTEIN TRANSPORT;

EID: 85032982370     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2017.10.020     Document Type: Article

References (63)

1. Amatsu, S., Sugawara, Y., Matsumura, T., Kitadokoro, K., Fujinaga, Y., Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex. J. Biol. Chem. 288 (2013), 35617–35625.
2. Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O., Caleo, M., Long-distance retrograde effects of botulinum neurotoxin A. J. Neurosci. 28 (2008), 3689–3696.
3. Benefield, D.A., Dessain, S.K., Shine, N., Ohi, M.D., Lacy, D.B., Molecular assembly of botulinum neurotoxin progenitor complexes. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 5630–5635.
4. Bigalke, H., Habermann, E., Blockade by tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus. N. Schmied. Arch. Pharmacol. 312 (1980), 255–263.
5. Black, J.D., Dolly, J.O., Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems. Neuroscience 23 (1987), 767–779.
6. Brookes, S.H., Classes of enteric nerve cells in the Guinea-pig small intestine. Anat. Rec. 262 (2001), 58–70.
7. Cheng, L.W., Onisko, B., Johnson, E.A., Reader, J.R., Griffey, S.M., Larson, A.E., Tepp, W.H., Stanker, L.H., Brandon, D.L., Carter, J.M., Effects of purification on the bioavailability of botulinum neurotoxin type A. Toxicology 249 (2008), 123–129.
8. Connan, C., Varela-Chavez, C., Mazuet, C., Molgo, J., Haustant, G.M., Disson, O., Lecuit, M., Vandewalle, A., Popoff, M.R., Translocation and dissemination to target neurons of botulinum neurotoxin type B in the mouse intestinal wall. Cell Microbiol. 18 (2016), 282–301.
9. Connan, C., Voillequin, M., Varela Chavez, C., Mazuet, C., Leveque, C., Vitry, S., Vandewalle, A., Popoff, M.R., Botulinum neurotoxin type B uses a distinct entry pathway mediated by Cdc42 into intestinal cells versus neuronal cells. Cell Microbiol., 19, 2017, e12738.
10. Couesnon, A., Colasante, C., Molgo, J., Popoff, M.R., Differential entry of Botulinum neurotoxin A into neuronal and intestinal cells: an ultrastructural approach. Botulinum J. 1 (2010), 375–392.
11. Couesnon, A., Molgo, J., Connan, C., Popoff, M.R., Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine. PLoS Pathog., 8, 2012, e1002583.
12. Couesnon, A., Pereira, Y., Popoff, M.R., Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers. Cell Microbiol. 10 (2008), 375–387.
13. Donaldson, D.S., Kobayashi, A., Ohno, H., Yagita, H., Williams, I.R., Mabbott, N.A., M cell-depletion blocks oral prion disease pathogenesis. Mucosal Immunol. 5 (2012), 216–225.
14. Elias, M., Al-Saleem, F., Ancharski, D.M., Singh, A., Nasser, Z., Olson, R.M., Simpson, L.L., Evidence that botulinum toxin receptors on epithelial cells and neuronal cells are not identical: implications for development of a non-neurotropic vaccine. J. Pharmacol. Exp. Ther. 336 (2011), 605–612.
15. Fujinaga, Y., Inoue, K., Watanabe, S., Yokota, K., Hirai, Y., Nagamachi, E., Oguma, K., The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of Guinea pig intestine, leading to the efficient absorption of the toxin. Microbiology 143 (1997), 3841–3847.
16. Fujinaga, Y., Sugawara, Y., Matsumura, T., Uptake of botulinum neurotoxin in the intestine. Curr. Top. Microbiol. Immunol. 364 (2013), 45–59.
17. Furness, J.B., Types of neurons in the enteric nervous system. J. Auton. Nerv. Syst. 81 (2000), 87–96.
18. Furness, J.B., The enteric nervous system and neurogastroenterology. Nat. Rev. Gastroenterol. Hepatol. 9 (2012), 286–294.
19. Furness, J.B., Callaghan, B.P., Rivera, L.R., Cho, H.J., The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv. Exp. Med. Biol. 817 (2014), 39–71.
20. Furness, J.B., Jones, C.A., Nurgali, K., Clerc, N., Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog. Neurobiol. 72 (2004), 143–164.
21. Goyal, R.K., Hirano, I., The enteric nervous system. N. Engl. J. Med. 334 (1996), 1106–1115.
22. Grundy, D., Schermann, M., Enteric nervous system. Curr. Opin. Gastroenterol. 22 (2006), 102–110.
23. Gu, S., Jin, R., Assembly and function of the botulinum neurotoxin progenitor complex. Curr. Top. Microbiol. Immunol. 364 (2013), 21–44, 10.1007/1978-1003-1642-33570-33579_33572.
24. Gu, S., Rumpel, S., Zhou, J., Strotmeier, J., Bigalke, H., Perry, K., Shoemaker, C.B., Rummel, A., Jin, R., Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science 335 (2012), 977–981.
25. Harrington, A.M., Hutson, J.M., Southwell, B.R., Cholinergic neurotransmission and muscarinic receptors in the enteric nervous system. Prog. Histochem. Cytochem. 44 (2010), 173–202.
26. Hase, K., Kawano, K., Nochi, T., Pontes, G.S., Fukuda, S., Ebisawa, M., Kadokura, K., Tobe, T., Fujimura, Y., Kawano, S., Yabashi, A., Waguri, S., Nakato, G., Kimura, S., Murakami, T., Iimura, M., Hamura, K., Fukuoka, S., Lowe, A.W., Itoh, K., Kiyono, H., Ohno, H., Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 462 (2009), 226–230.
27. Hernandes, L., Gama, P., Alvares, E.P., Ileal VIP submucous neurons: confocal study of the area enlargement induced by myenteric denervation in weanling rats. Regul. Pept. 117 (2004), 69–72.
28. Igarashi, H., Fujimori, N., Ito, T., Nakamura, T., Oono, T., Nakamura, K., Suzuki, K., Jensen, R.T., Takayanaga, R., Vasoactive intestinal peptide (VIP) and VIP receptors - elucidation of structure and function for therapeutic applications. Int. J. Clin. Med. 2 (2011), 500–508.
29. James, A.N., Ryan, J.P., Parkman, H.P., Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003), G291–G297.
30. Jin, Y., Takegahara, Y., Sugawara, Y., Matsumura, T., Fujinaga, Y., Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology 155 (2009), 35–45.
31. Kerneis, S., Bogdanova, A., Kraenhenbul, J.P., Pringault, E., Conversion by Payer's patche lymphocyte of human enterocytes into M cells that transport bacteria. Science 277 (1997), 949–952.
32. Knoop, K.A., Kumar, N., Butler, B.R., Sakthivel, S.K., Taylor, R.T., Nochi, T., Akiba, H., Yagita, H., Kiyono, H., Williams, I.R., RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J. Immunol. 183 (2009), 5738–5747.
33. Lam, T.I., Stanker, L.H., Lee, K., Jin, R., Cheng, L.W., Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia. Cell Microbiol. 17 (2015), 1133–1143.
34. Lee, K., Gu, S., Jin, L., Le, T.T., Cheng, L.W., Strotmeier, J., Kruel, A.M., Yao, G., Perry, K., Rummel, A., Jin, R., Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog., 9, 2013, e1003690.
35. Lee, K., Zhong, X., Gu, S., Kruel, A.M., Dorner, M.B., Perry, K., Rummel, A., Dong, M., Jin, R., Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344 (2014), 1405–1410.
36. Mabbott, N.A., Donaldson, D.S., Ohno, H., Williams, I.R., Mahajan, A., Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 6 (2013), 666–677.
37. MacKenzie, I., Burnstock, G., Dolly, J.O., The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 7 (1982), 997–1006.
38. Maksymowych, A.B., Simpson, L.I., Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells. J. Pharmacol. Exp. Ther. 310 (2004), 633–641.
39. Matsumura, T., Jin, Y., Kabumoto, Y., Takegahara, Y., Oguma, K., Lencer, W.I., Fujinaga, Y., The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell Microbiol. 10 (2008), 355–364.
40. Matsumura, T., Sugawara, Y., Yutani, M., Amatsu, S., Yagita, H., Kohda, T., Fukuoka, S., Nakamura, Y., Fukuda, S., Hase, K., Ohno, H., Fujinaga, Y., Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity. Nat. Commun., 6, 2015, 6255.
41. Mawe, G.M., Hoffman, J.M., Serotonin signalling in the gut–functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 10 (2013), 473–486.
42. Mayor, S., Pagano, R.E., Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8 (2007), 603–612.
43. McLean, P.G., Borman, R.A., Lee, K., 5-HT in the enteric nervous system: gut function and neuropharmacology. Trends Neurosci. 30 (2007), 9–13.
44. Nakato, G., Hase, K., Suzuki, M., Kimura, M., Ato, M., Hanazato, M., Tobiume, M., Horiuchi, M., Atarashi, R., Nishida, N., Watarai, M., Imaoka, K., Ohno, H., Cutting Edge: Brucella abortus exploits a cellular prion protein on intestinal M cells as an invasive receptor. J. Immunol. 189 (2012), 1540–1544.
45. Neutra, M.R., Mantis, N.J., Kraehenbuhl, J.P., Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2 (2001), 1004–1009.
46. Oguma, K., Inoue, K., Fujinaga, Y., Yokota, K., Watanabe, T., Ohyama, T., Takeshi, K., Inoue, K., Structure and function of Clostridium botulinum progenitor toxin. J. Toxicol. 18 (1999), 17–34.
47. Ouzilou, L., Caliot, M., Pelletier, I., Prévost, M.C., Pringault, E., Colbère-Garapin, F., Poliovirus transcytosis through M-like cells. J. Gen. Virol. 83 (2002), 2177–2182.
48. Pasricha, P.J., Ravich, W.J., Kalloo, A.N., Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 105 (1993), 1045–1049.
49. Peck, M.W., Smith, T.J., Anniballi, F., Austin, J.W., Bano, L., Bradshaw, M., Cuervo, P., Cheng, L.W., Derman, Y., Dorner, B.G., Fisher, A., Hill, K.K., Kalb, S.R., Korkeala, H., Lindstrom, M., Lista, F., Luquez, C., Mazuet, C., Pirazzini, M., Popoff, M.R., Rossetto, O., Rummel, A., Sesardic, D., Singh, B.R., Stringer, S.C., Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature. Toxins (Basel), 9, 2017.
50. Poulain, B., Molgo, J., Popoff, M.R., Clostridial neurotoxins: from the cellular and molecular mode of action to their therapeutic use. Alouf, J., Ladant, D., Popoff, M.R., (eds.) The Comprehensive Sourcebook of Bacterial Protein Toxins, fourth ed., 2015, Elsevier, Amsterdam, 287–336.
51. Restani, L., Antonucci, F., Gianfranceschi, L., Rossi, C., Rossetto, O., Caleo, M., Evidence for anterograde transport and transcytosis of botulinum neurotoxin a (BoNT/A). J. Neurosci. 31 (2011), 15650–15659.
52. Restani, L., Giribaldi, F., Manich, M., Bercsenyi, K., Menendez, G., Rossetto, O., Caleo, M., Schiavo, G., Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathog., 8, 2012, e1003087.
53. Roux, A., Uyhazi, K., Frost, A., De Camilli, P., GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission. Nature 441 (2006), 528–531.
54. Rummel, A., Two feet on the membrane: uptake of clostridial neurotoxins. Curr. Top. Microbiol. Immunol., 48, 2016, 10.1007/82.
55. cc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol. Microbiol. 51 (2004), 631–643.
56. Sakaguchi, G., Clostridium botulinum toxins. Pharmac. Ther. 19 (1983), 165–194.
57. Sand, J., Nordback, I., Arvola, P., Porsti, I., Kalloo, A., Pasricha, P., Effects of botulinum toxin A on the sphincter of Oddi: an in vivo and in vitro study. Gut 42 (1998), 507–510.
58. Sato, S., Kaneto, S., Shibata, N., Takahashi, Y., Okura, H., Yuki, Y., Kunisawa, J., Kiyono, H., Transcription factor Spi-B-dependent and -independent pathways for the development of Peyer's patch M cells. Mucosal Immunol. 6 (2013), 838–846.
59. Serafini-Cessi, F., Malagolini, N., Cavallone, D., Tamm-Horsfall glycoprotein: biology and clinical relevance. Am. J. Kidney Dis. 42 (2003), 658–676.
60. Sobel, J., Botulism. Clin. Infect. Dis. 41 (2005), 1167–1173.
61. Sugawara, Y., Matsumura, T., Takegahara, Y., Jin, Y., Tsukasaki, Y., Takeichi, M., Fujinaga, Y., Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. J. Cell Biol. 189 (2010), 691–700.
62. Sugii, S., Ohishi, I., Sakaguchi, G., Intestinal absorption of botulinum toxins of different molecular sizes in rats. Infect. Immun. 17 (1977), 491–496.
63. Takei, K., Yoshida, Y., Yamada, H., Regulatory mechanisms of dynamin-dependent endocytosis. J. Biochem. (Tokyo) 137 (2005), 243–247.